---
schema_version: "secwatch.filing_event.v1"
accession: "0001588978-25-000004"
form_type: "8-K"
ticker: "PRCT"
cik: "0001588978"
company_name: "PROCEPT BioRobotics Corp"
filed_at: "2025-02-25T23:59:59+00:00"
generated_at: "2026-05-26T04:46:07.406369+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# PROCEPT BioRobotics Q4 revenue up 57% to $68.2M; guides FY2025 revenue ~$320M (+42%)

## Summary
- Q4 rev $68.2M (+57% YoY); US system rev $27.6M (+67%); handpiece rev $29.3M (+36%).
- FY2024 rev $224.5M (+65%); net loss narrowed to $91.4M from $105.9M; adj EBITDA loss $61.1M vs $86.5M.
- FY2025 guidance: rev ~$320M (+42%); gross margin ~64.5%; adj EBITDA loss ~$35M.
- Cash $333.7M, debt $52.0M; US install base 505 AquaBeam/HYDROS systems.
- Q4 saline shortage delayed ~10-20% of Aquablation procedures, impacting handpiece order patterns.

## SEC filing metadata
- accession: 0001588978-25-000004
- form_type: 8-K
- ticker: PRCT
- cik: 0001588978
- company_name: PROCEPT BioRobotics Corp
- filed_at: 2025-02-25T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1588978/000158897825000004/0001588978-25-000004-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1588978/000158897825000004/prct-20250225.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001588978-25-000004
- JSON: https://secwatch.observer/filing/0001588978-25-000004.json
- Plain text: https://secwatch.observer/filing/0001588978-25-000004.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.